home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

61.14 +0.72 (+1.19%)

Streaming Delayed Price Updated: 11:09 AM EDT, Jun 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

99 100 Next >

Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance Cut: Retail’s Shaken ↗

January 13, 2025

The revised projection largely reflects declining COVID-19 vaccine demand, as fewer people seek boosters amid the ongoing shift to an endemic phase.

Via Stocktwits

Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 Guidance ↗

January 13, 2025

The company also had a setback for its CMV vaccine.

Via Investor's Business Daily

Moderna Expects Lower Annual Sales, Expands Cost-Cutting Initiatives ↗

January 13, 2025

Moderna targets ten product approvals by 2027 while cutting R&D costs by $1.1 billion. FY2024 revenue reached $3 billion-$3.1 billion, with $9.5B in cash reserves.

Via Benzinga

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference

January 13, 2025

Via ACCESSWIRE

MarketBeat Week in Review – 01/06 - 01/10

January 11, 2025

Stocks continued to slide after a hot jobs report sent bond yields higher, lowered expectations for future rate cuts, and keeps inflation and earnings in focus

Via MarketBeat

Spotlight on Moderna: Analyzing the Surge in Options Activity ↗

January 07, 2025

Via Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today ↗

January 07, 2025

Via Benzinga

Peering Into Moderna's Recent Short Interest ↗

December 31, 2024

Via Benzinga

10 Worst Performing Large-Caps Last 12 Months ↗

January 09, 2025

Here’s this week’s top ten worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. ↗

January 09, 2025

Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.

Via Investor's Business Daily

Topics Artificial Intelligence Government

"Motley Fool Money" 2025 Stock Market Preview ↗

January 08, 2025

New year, new market? Motley Fool analysts preview what's in store for investors in 2025, the companies they're excited to watch and the businesses they're worried about.

Via The Motley Fool

Is Moderna Stock a Buy? ↗

December 20, 2024

Via The Motley Fool

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies ↗

January 08, 2025

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Via Benzinga

Topics ETFs

Moderna Shares Spike on H5N1 News—What’s Next for Investors?

January 08, 2025

MRNA stock surged over 12% on growing bird flu concerns; that rally may not last, but analysts believe the company's pipeline makes the stock a Buy in 2025

Via MarketBeat

Prediction: These Could Be the Best-Performing Value Stocks Through 2030 ↗

January 08, 2025

Via The Motley Fool

Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

January 07, 2025

The U.S. stock market experienced a downturn on Tuesday, with the Nasdaq Composite falling by 1.9% and the S&P 500 dropping by 1.1%..

Via Benzinga

Topics Stocks

Stocks Sink As Bond Yields Soar, Nvidia Eyes Worst Day In 4 Months, Bitcoin Tumbles To $97,000: What's Driving Markets Tuesday? ↗

January 07, 2025

Tuesday began as a calm day on Wall Street, but markets swiftly turned negative after the Institute for Supply Management released data highlighting an unexpected surge in price pressures within the...

Via Benzinga

Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike ↗

January 07, 2025

Moderna, BioNTech and Novavax stocks popped after the CDC noted a recent increase in positive Covid tests.

Via Investor's Business Daily

S&P 500, Nasdaq Fall As Economic Data, Bond Yields Weigh ↗

January 07, 2025

Stocks are mostly lower today, with the S&P 500 Index and Nasdaq Composite Index erasing early-morning gains.

Via Talk Markets

Topics Stocks Stocks / Equities

US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally ↗

January 07, 2025

The Louisiana Department of Health on Monday reported the first human death in the U.S. related to the H5N1 bird flu virus. The CDC is also reporting high levels of acute respiratory illnesses...

Via Benzinga

UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

January 07, 2025

Via Benzinga

Investors Look Back at 2024 ↗

January 06, 2025

The S&P 500 had a great year.

Via The Motley Fool

Topics Stocks

Why Moderna (MRNA) Stock Is Trading Higher ↗

January 06, 2025

Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory illnesses across the United States.

Via Benzinga

3 Growth Stocks That Could Skyrocket in 2025 and Beyond ↗

January 05, 2025

The proverbial planets are aligning for these three companies, and their stocks.

Via The Motley Fool

10 Worst Performing Large-Caps Last 12 Months ↗

January 02, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Meet the Newest Stock in the Nasdaq-100. It's Soared 110,600% Since Its IPO and It's Still a Buy Heading Into 2025, According to Wall Street. ↗

December 27, 2024

Shares of this specialty technology company have gained 141% over the past year, and that could be just the beginning.

Via The Motley Fool

Topics Initial Public Offering

10 Worst Performing Large-Caps Last 12 Months ↗

December 26, 2024

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

US Stocks To Open Higher As Wall Street Expects 'Santa Rally' In Shortened Trading Week: MicroStrategy, Palantir, Qualcomm Among Stocks In Focus ↗

December 23, 2024

U.S. stock futures advanced on Monday as two out of the four major index futures were trading higher in premarket trade.

Via Benzinga

Large-Cap Stocks In Trouble - Saturday, Dec. 21 ↗

December 21, 2024

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Via Talk Markets

Topics Stocks / Equities

3 Stocks That Could Turn $1,000 into $5,000 by 2030 ↗

December 20, 2024

Via The Motley Fool

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com